WASHINGTON, Sept. 28 /PRNewswire/ -- Statement attributable to: Stephen C. Hammill, M.D., President, Heart Rhythm Society (formerly NASPE) "We are pleased that the Centers for Medicare and Medicaid Services (CMS) has decided to expand coverage of implantable cardioverter defibrillator devices (ICDs) for heart failure patients at risk for sudden cardiac death (SCD). We are concerned, however, that establishing a registry could delay patients from receiving this lifesaving therapy. "In addition, we support CMS' deletion of the limitation of only implanting devices in heart attack survivor patients with a QRS duration of greater than 120 ms, as recommended by HRS. "As the professional society for heart rhythm specialists who diagnose and treat patients with heart rhythm disorders and heart failure, we have other concerns with the following requirements listed in the CMS decision: * A limitation of coverage to patients with an ejection fraction of less than 30 percent; * Exclusion of Class IV patients who require cardiac resynchronization therapy; * The requirement of single lead, shock-only devices as a baseline for coverage without additional pacing capabilities. "We look forward to submitting comments and working with CMS to address these concerns. We strongly support CMS' decision to expand access to a technology that has been proven to save lives." The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. The Society was incorporated in 1979, and has a membership of over 3,500 physicians and associated professionals in over 65 countries around the world. It has offices in Washington, DC and Natick, MA.
SOURCE Heart Rhythm Society